Concepts (276)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endopeptidases | 11 | 2023 | 34 | 3.030 |
Why?
|
| Mitochondrial Proteins | 10 | 2023 | 77 | 2.880 |
Why?
|
| RNA-Binding Proteins | 6 | 2017 | 70 | 2.120 |
Why?
|
| Mutation | 15 | 2023 | 532 | 2.040 |
Why?
|
| Mitochondria | 6 | 2017 | 219 | 1.530 |
Why?
|
| Mice | 29 | 2024 | 2720 | 1.440 |
Why?
|
| Mitochondrial Membranes | 5 | 2023 | 27 | 1.290 |
Why?
|
| Gene Transfer Techniques | 2 | 2019 | 66 | 1.160 |
Why?
|
| Animals | 34 | 2024 | 8579 | 1.090 |
Why?
|
| Chloride Channels | 2 | 2024 | 7 | 1.080 |
Why?
|
| Pharmaceutical Preparations | 2 | 2021 | 40 | 1.040 |
Why?
|
| Spermatogenesis | 5 | 2017 | 50 | 1.030 |
Why?
|
| Testis | 7 | 2012 | 72 | 0.990 |
Why?
|
| MicroRNAs | 2 | 2018 | 197 | 0.930 |
Why?
|
| Antioxidants | 2 | 2017 | 126 | 0.930 |
Why?
|
| Transgenes | 2 | 2024 | 52 | 0.880 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2022 | 5 | 0.840 |
Why?
|
| Animals, Newborn | 1 | 2024 | 143 | 0.840 |
Why?
|
| Energy Metabolism | 2 | 2014 | 169 | 0.730 |
Why?
|
| Adiposity | 2 | 2014 | 204 | 0.710 |
Why?
|
| Nanoparticles | 2 | 2019 | 58 | 0.710 |
Why?
|
| Testicular Hormones | 4 | 2005 | 6 | 0.710 |
Why?
|
| Oxidative Stress | 6 | 2017 | 265 | 0.700 |
Why?
|
| Reactive Oxygen Species | 4 | 2017 | 174 | 0.690 |
Why?
|
| Mice, Transgenic | 7 | 2017 | 279 | 0.690 |
Why?
|
| Hepatocytes | 2 | 2023 | 84 | 0.680 |
Why?
|
| Reading Frames | 1 | 2020 | 2 | 0.660 |
Why?
|
| Exons | 1 | 2020 | 53 | 0.650 |
Why?
|
| Ribonucleoproteins | 1 | 2019 | 15 | 0.610 |
Why?
|
| Transfection | 2 | 2019 | 216 | 0.590 |
Why?
|
| Ovary | 3 | 2016 | 69 | 0.570 |
Why?
|
| Bacterial Proteins | 1 | 2019 | 100 | 0.560 |
Why?
|
| Mice, Knockout | 5 | 2024 | 486 | 0.550 |
Why?
|
| Genetic Vectors | 4 | 2024 | 127 | 0.540 |
Why?
|
| Adaptor Protein Complex 2 | 1 | 2017 | 3 | 0.540 |
Why?
|
| RNA, Messenger | 5 | 2022 | 545 | 0.530 |
Why?
|
| Mutagenesis, Insertional | 2 | 2007 | 17 | 0.530 |
Why?
|
| Plastoquinone | 1 | 2017 | 1 | 0.530 |
Why?
|
| Natronobacterium | 1 | 2017 | 2 | 0.520 |
Why?
|
| Nitric Oxide | 3 | 2013 | 124 | 0.520 |
Why?
|
| Infertility, Male | 1 | 2017 | 24 | 0.520 |
Why?
|
| Exosomes | 1 | 2017 | 45 | 0.510 |
Why?
|
| Neurons | 3 | 2015 | 491 | 0.500 |
Why?
|
| RNA, Messenger, Stored | 1 | 2016 | 1 | 0.490 |
Why?
|
| Genes, fos | 1 | 2016 | 5 | 0.490 |
Why?
|
| Eating | 2 | 2013 | 81 | 0.480 |
Why?
|
| Oocytes | 1 | 2016 | 48 | 0.460 |
Why?
|
| Proteins | 4 | 2005 | 155 | 0.450 |
Why?
|
| Apoptosis | 3 | 2017 | 400 | 0.450 |
Why?
|
| Plasmids | 4 | 2019 | 52 | 0.430 |
Why?
|
| Oxygen Consumption | 2 | 2014 | 167 | 0.430 |
Why?
|
| Carrier Proteins | 2 | 2005 | 149 | 0.410 |
Why?
|
| Spermatozoa | 3 | 2017 | 30 | 0.370 |
Why?
|
| Humans | 19 | 2024 | 34562 | 0.370 |
Why?
|
| Mice, Inbred C57BL | 5 | 2018 | 842 | 0.370 |
Why?
|
| Growth | 1 | 2012 | 7 | 0.360 |
Why?
|
| Growth Plate | 1 | 2012 | 5 | 0.360 |
Why?
|
| Rats | 3 | 2007 | 1946 | 0.360 |
Why?
|
| Dystrophin | 2 | 2022 | 4 | 0.350 |
Why?
|
| Motor Activity | 1 | 2014 | 356 | 0.350 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 87 | 0.350 |
Why?
|
| Chondrocytes | 1 | 2012 | 70 | 0.350 |
Why?
|
| Signal Transduction | 2 | 2024 | 771 | 0.350 |
Why?
|
| Aging, Premature | 1 | 2011 | 4 | 0.340 |
Why?
|
| Adult Stem Cells | 1 | 2011 | 26 | 0.330 |
Why?
|
| Regenerative Medicine | 1 | 2013 | 219 | 0.330 |
Why?
|
| Male | 17 | 2017 | 20740 | 0.320 |
Why?
|
| Genes, Reporter | 2 | 2020 | 44 | 0.310 |
Why?
|
| Lentivirus | 2 | 2019 | 11 | 0.300 |
Why?
|
| Kidney | 3 | 2024 | 528 | 0.290 |
Why?
|
| Age Factors | 1 | 2012 | 1262 | 0.290 |
Why?
|
| DNA Transposable Elements | 2 | 2012 | 16 | 0.290 |
Why?
|
| Mice, Mutant Strains | 5 | 2014 | 56 | 0.280 |
Why?
|
| Infertility | 2 | 2007 | 21 | 0.280 |
Why?
|
| Female | 14 | 2018 | 21532 | 0.270 |
Why?
|
| Staphylococcus aureus | 2 | 2019 | 58 | 0.270 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2005 | 73 | 0.270 |
Why?
|
| Superoxides | 3 | 2015 | 24 | 0.270 |
Why?
|
| Transcription Factors | 3 | 2023 | 192 | 0.270 |
Why?
|
| Gene Expression | 2 | 2022 | 363 | 0.260 |
Why?
|
| Cell Membrane Structures | 1 | 2005 | 1 | 0.230 |
Why?
|
| Acrosome | 1 | 2005 | 2 | 0.230 |
Why?
|
| Fibroblasts | 2 | 2021 | 122 | 0.230 |
Why?
|
| Fibrosis | 2 | 2024 | 131 | 0.230 |
Why?
|
| Nephrolithiasis | 1 | 2024 | 3 | 0.220 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2024 | 9 | 0.220 |
Why?
|
| Lysosomes | 1 | 2024 | 11 | 0.210 |
Why?
|
| Molecular Sequence Data | 5 | 2012 | 389 | 0.210 |
Why?
|
| Base Sequence | 3 | 2019 | 265 | 0.210 |
Why?
|
| beta Catenin | 1 | 2024 | 39 | 0.210 |
Why?
|
| Blotting, Western | 4 | 2017 | 328 | 0.210 |
Why?
|
| Sequence Alignment | 2 | 2019 | 62 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 1 | 2024 | 216 | 0.200 |
Why?
|
| Adipose Tissue, Brown | 2 | 2014 | 8 | 0.200 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 1129 | 0.200 |
Why?
|
| Dependovirus | 2 | 2022 | 20 | 0.190 |
Why?
|
| Spermatogonia | 1 | 2003 | 15 | 0.190 |
Why?
|
| Fertility | 1 | 2003 | 32 | 0.190 |
Why?
|
| Eukaryota | 1 | 2022 | 4 | 0.190 |
Why?
|
| Endonucleases | 1 | 2022 | 5 | 0.190 |
Why?
|
| Reperfusion Injury | 1 | 2023 | 60 | 0.190 |
Why?
|
| Ischemic Attack, Transient | 1 | 2023 | 57 | 0.190 |
Why?
|
| DNA | 2 | 2022 | 235 | 0.190 |
Why?
|
| Amino Acid Sequence | 5 | 2007 | 319 | 0.190 |
Why?
|
| Gene Products, gag | 1 | 2022 | 3 | 0.180 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2022 | 15 | 0.180 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 526 | 0.180 |
Why?
|
| Brain | 4 | 2013 | 1032 | 0.180 |
Why?
|
| Oligonucleotides | 1 | 2022 | 31 | 0.180 |
Why?
|
| Body Weight | 2 | 2014 | 343 | 0.180 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2014 | 124 | 0.180 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 170 | 0.180 |
Why?
|
| Fanconi Anemia Complementation Group L Protein | 3 | 2006 | 4 | 0.180 |
Why?
|
| Green Fluorescent Proteins | 2 | 2019 | 72 | 0.170 |
Why?
|
| Oogenesis | 2 | 2016 | 6 | 0.170 |
Why?
|
| Spheroids, Cellular | 1 | 2021 | 39 | 0.170 |
Why?
|
| Cell Line | 4 | 2012 | 476 | 0.170 |
Why?
|
| INDEL Mutation | 1 | 2020 | 11 | 0.170 |
Why?
|
| Blood Glucose | 2 | 2014 | 529 | 0.170 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2020 | 30 | 0.160 |
Why?
|
| Two-Hybrid System Techniques | 3 | 2005 | 9 | 0.160 |
Why?
|
| Capsid Proteins | 1 | 2019 | 9 | 0.150 |
Why?
|
| Capsid | 1 | 2019 | 9 | 0.150 |
Why?
|
| Aptamers, Nucleotide | 1 | 2019 | 11 | 0.150 |
Why?
|
| RNA, Guide | 1 | 2019 | 3 | 0.150 |
Why?
|
| Cells, Cultured | 2 | 2013 | 889 | 0.130 |
Why?
|
| Seminiferous Tubules | 1 | 2017 | 3 | 0.130 |
Why?
|
| Homozygote | 1 | 2017 | 59 | 0.130 |
Why?
|
| Thermus thermophilus | 1 | 2017 | 2 | 0.130 |
Why?
|
| Protein Binding | 1 | 2017 | 255 | 0.130 |
Why?
|
| Genome, Human | 1 | 2017 | 136 | 0.120 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2016 | 10 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2016 | 13 | 0.120 |
Why?
|
| Protein Isoforms | 1 | 2016 | 63 | 0.120 |
Why?
|
| Organ Specificity | 1 | 2016 | 86 | 0.120 |
Why?
|
| Purkinje Cells | 1 | 2015 | 3 | 0.120 |
Why?
|
| Obesity | 2 | 2014 | 1246 | 0.120 |
Why?
|
| Tissue Engineering | 1 | 2021 | 700 | 0.110 |
Why?
|
| Spodoptera | 1 | 2014 | 5 | 0.110 |
Why?
|
| Baculoviridae | 1 | 2014 | 6 | 0.110 |
Why?
|
| Alternative Splicing | 2 | 2005 | 34 | 0.110 |
Why?
|
| Germ Cells | 2 | 2005 | 12 | 0.110 |
Why?
|
| Mice, Obese | 1 | 2014 | 24 | 0.110 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 2 | 2014 | 8 | 0.100 |
Why?
|
| Cyclic GMP | 1 | 2013 | 23 | 0.100 |
Why?
|
| Hyperglycemia | 1 | 2014 | 88 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 281 | 0.100 |
Why?
|
| Fatty Liver | 1 | 2014 | 70 | 0.100 |
Why?
|
| Hyperlipidemias | 1 | 2014 | 61 | 0.100 |
Why?
|
| Phenotype | 2 | 2007 | 657 | 0.100 |
Why?
|
| Triglycerides | 1 | 2014 | 249 | 0.100 |
Why?
|
| Nicotinamide-Nucleotide Adenylyltransferase | 1 | 2012 | 7 | 0.100 |
Why?
|
| Nucleotidyltransferases | 1 | 2012 | 10 | 0.100 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 35 | 0.090 |
Why?
|
| Axons | 1 | 2012 | 36 | 0.090 |
Why?
|
| Ion Channels | 1 | 2012 | 27 | 0.090 |
Why?
|
| Pluripotent Stem Cells | 1 | 2012 | 18 | 0.090 |
Why?
|
| Protein Carbonylation | 1 | 2012 | 3 | 0.090 |
Why?
|
| Glutathione Peroxidase | 1 | 2012 | 10 | 0.090 |
Why?
|
| Leptin | 1 | 2012 | 75 | 0.090 |
Why?
|
| Bone Development | 1 | 2012 | 8 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 44 | 0.090 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 229 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2012 | 145 | 0.090 |
Why?
|
| Bone and Bones | 1 | 2012 | 99 | 0.090 |
Why?
|
| Ataxia | 1 | 2011 | 8 | 0.090 |
Why?
|
| Kyphosis | 1 | 2011 | 11 | 0.090 |
Why?
|
| Wasting Syndrome | 1 | 2011 | 14 | 0.090 |
Why?
|
| Lipids | 1 | 2012 | 267 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2014 | 488 | 0.080 |
Why?
|
| Adipose Tissue | 1 | 2013 | 366 | 0.080 |
Why?
|
| Brain Injuries | 1 | 2011 | 94 | 0.080 |
Why?
|
| Genotype | 1 | 2012 | 744 | 0.080 |
Why?
|
| Sarcopenia | 1 | 2011 | 67 | 0.080 |
Why?
|
| Urinary Bladder Diseases | 1 | 2010 | 45 | 0.080 |
Why?
|
| HIV-1 | 1 | 2009 | 46 | 0.070 |
Why?
|
| Aging | 1 | 2015 | 1010 | 0.070 |
Why?
|
| Sex Factors | 1 | 2011 | 708 | 0.070 |
Why?
|
| Adult | 2 | 2021 | 10030 | 0.070 |
Why?
|
| Cell Nucleus | 2 | 2009 | 119 | 0.070 |
Why?
|
| Adenosine Triphosphatases | 1 | 2007 | 14 | 0.070 |
Why?
|
| Ovulation | 1 | 2007 | 10 | 0.070 |
Why?
|
| Adenosine Triphosphate | 1 | 2007 | 75 | 0.070 |
Why?
|
| Ovarian Follicle | 1 | 2007 | 37 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 2 | 2005 | 142 | 0.070 |
Why?
|
| Monophenol Monooxygenase | 1 | 2007 | 2 | 0.070 |
Why?
|
| Animals, Genetically Modified | 1 | 2007 | 69 | 0.060 |
Why?
|
| Erectile Dysfunction | 1 | 2007 | 71 | 0.060 |
Why?
|
| Fanconi Anemia | 1 | 2005 | 2 | 0.060 |
Why?
|
| Ligases | 1 | 2005 | 5 | 0.060 |
Why?
|
| Antibodies | 1 | 2006 | 59 | 0.060 |
Why?
|
| Proteome | 1 | 2006 | 41 | 0.060 |
Why?
|
| Models, Animal | 2 | 2003 | 198 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2005 | 35 | 0.060 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 48 | 0.060 |
Why?
|
| Yeasts | 1 | 2005 | 7 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 36 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2005 | 31 | 0.060 |
Why?
|
| Species Specificity | 1 | 2005 | 101 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2005 | 71 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2005 | 111 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 86 | 0.050 |
Why?
|
| Collagen Type I | 1 | 2024 | 48 | 0.050 |
Why?
|
| Conotoxins | 1 | 2003 | 1 | 0.050 |
Why?
|
| Snails | 1 | 2003 | 2 | 0.050 |
Why?
|
| Electron Transport Complex III | 1 | 2023 | 2 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2003 | 54 | 0.050 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2023 | 30 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2023 | 43 | 0.050 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2023 | 16 | 0.050 |
Why?
|
| Peptides | 1 | 2003 | 143 | 0.050 |
Why?
|
| Mutagenesis | 2 | 2012 | 35 | 0.050 |
Why?
|
| Analgesics | 1 | 2003 | 117 | 0.050 |
Why?
|
| Octamer Transcription Factor-3 | 2 | 2014 | 20 | 0.050 |
Why?
|
| SOXB1 Transcription Factors | 2 | 2014 | 18 | 0.050 |
Why?
|
| Mice, Inbred mdx | 1 | 2022 | 1 | 0.050 |
Why?
|
| Kanamycin Kinase | 1 | 2002 | 6 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2002 | 42 | 0.050 |
Why?
|
| Genetic Markers | 1 | 2002 | 132 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2022 | 575 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 35 | 0.030 |
Why?
|
| Time Factors | 2 | 2011 | 2353 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2015 | 48 | 0.030 |
Why?
|
| Erythropoietin | 1 | 2015 | 33 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 67 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 55 | 0.030 |
Why?
|
| Creatinine | 1 | 2015 | 206 | 0.030 |
Why?
|
| Collagen | 1 | 2015 | 240 | 0.030 |
Why?
|
| CHO Cells | 1 | 2012 | 29 | 0.020 |
Why?
|
| Ganciclovir | 1 | 2012 | 23 | 0.020 |
Why?
|
| Hindlimb | 1 | 2012 | 55 | 0.020 |
Why?
|
| Cricetinae | 1 | 2012 | 52 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2012 | 23 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2012 | 74 | 0.020 |
Why?
|
| Hela Cells | 1 | 2012 | 82 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2012 | 47 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 99 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 85 | 0.020 |
Why?
|
| Motor Neurons | 1 | 2012 | 66 | 0.020 |
Why?
|
| Ganglia, Spinal | 1 | 2012 | 72 | 0.020 |
Why?
|
| Cell Transplantation | 1 | 2012 | 65 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 198 | 0.020 |
Why?
|
| Dicarbethoxydihydrocollidine | 1 | 2011 | 1 | 0.020 |
Why?
|
| Circle of Willis | 1 | 2011 | 2 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2011 | 21 | 0.020 |
Why?
|
| Brain Infarction | 1 | 2011 | 10 | 0.020 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2015 | 302 | 0.020 |
Why?
|
| DNA Damage | 1 | 2011 | 97 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 508 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2011 | 160 | 0.020 |
Why?
|
| Protein Denaturation | 1 | 2009 | 16 | 0.020 |
Why?
|
| Rosaniline Dyes | 1 | 2009 | 19 | 0.020 |
Why?
|
| Stem Cells | 1 | 2012 | 331 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2009 | 18 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2009 | 46 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2009 | 29 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 103 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2009 | 66 | 0.020 |
Why?
|
| Hemagglutinins | 1 | 2006 | 6 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2006 | 45 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2006 | 77 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2006 | 92 | 0.010 |
Why?
|
| Rabbits | 1 | 2006 | 231 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 281 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2006 | 271 | 0.010 |
Why?
|
| Lung | 1 | 2006 | 279 | 0.010 |
Why?
|
| Goldfish | 1 | 2003 | 1 | 0.010 |
Why?
|
| Protein Folding | 1 | 2003 | 31 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2005 | 633 | 0.010 |
Why?
|
| Embryo Loss | 1 | 2002 | 3 | 0.010 |
Why?
|
| Fetal Weight | 1 | 2002 | 7 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2002 | 12 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 99 | 0.010 |
Why?
|
| Cell Movement | 1 | 2002 | 182 | 0.010 |
Why?
|
| Pain | 1 | 2003 | 330 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2002 | 485 | 0.010 |
Why?
|